{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:16:16Z","timestamp":1793196976526,"version":"4.5.0"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21DA031906"],"award-info":[{"award-number":["R21DA031906"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0190768","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T13:40:00Z","timestamp":1517406000000},"page":"e0190768","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":115,"title":["Nabiximols combined with motivational enhancement\/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial"],"prefix":"10.1371","volume":"13","author":[{"given":"Jose M.","family":"Trigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena C.","family":"Quilty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Selby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan J.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn A.","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony P.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Streiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Staios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-4973","authenticated-orcid":true,"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,1,31]]},"reference":[{"key":"ref1","unstructured":"UNODC (2016) United Nations Office on Drugs and Crime. World Drug Report 2016. New York: United Nations."},{"key":"ref2","unstructured":"UNODC (2015) United Nations Office on Drugs and Crime. World Drug Report 2015. In: Nations U, editor. New York"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/pubmed\/fdv005","article-title":"Crude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities","volume":"38","author":"B Fischer","year":"2016","journal-title":"J Public Health (Oxf)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF03405515","article-title":"Cannabis use in Canada: the need for a 'public health' approach","volume":"100","author":"B Fischer","year":"2009","journal-title":"Can J Public Health"},{"key":"ref5","article-title":"Cannabis policy: Moving beyond stalemate","author":"R Room","year":"2010"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/ADM.0b013e31820cdd57","article-title":"Effects of chronic, heavy cannabis use on executive functions","volume":"5","author":"RD Crean","year":"2011","journal-title":"J Addict Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"71S","DOI":"10.1002\/j.1552-4604.2002.tb06006.x","article-title":"Respiratory and immunologic consequences of marijuana smoking","volume":"42","author":"DP Tashkin","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(14)00117-5","article-title":"Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study","volume":"2","author":"M Di Forti","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drugalcdep.2015.06.015","article-title":"Cannabis effects on driving lateral control with and without alcohol","volume":"154","author":"RL Hartman","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of Marijuana Use Disorders in the United States Between 2001\u20132002 and 2012\u20132013","volume":"72","author":"DS Hasin","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.drugalcdep.2007.08.005","article-title":"Likelihood of developing an alcohol and cannabis use disorder during youth: association with recent use and age","volume":"92","author":"KC Winters","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1521-0391.2013.00321.x","article-title":"Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample","volume":"22","author":"S Lev-Ran","year":"2013","journal-title":"Am J Addict"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0893-133X(01)00367-0","article-title":"From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol","volume":"26","author":"FA Wagner","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"ref14","first-page":"CD008940","article-title":"Pharmacotherapies for cannabis dependence","volume":"12","author":"K Marshall","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref15","unstructured":"WHO (2016) World Health Organization. The health and social effects of nonmedical cannabis use. WHO Library Cataloguing-in-Publication Data."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/SAR.S89857","article-title":"Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review","volume":"7","author":"J Copeland","year":"2016","journal-title":"Subst Abuse Rehabil"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1016\/bs.irn.2016.02.005","article-title":"Screening and Evaluation of Medications for Treating Cannabis Use Disorder","author":"LV Panlilio","year":"2016","journal-title":"International Review of Neurobiology In production"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2165\/00023210-200923070-00001","article-title":"Pharmacotherapy for cannabis dependence: how close are we?","volume":"23","author":"R Vandrey","year":"2009","journal-title":"CNS Drugs"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.drugalcdep.2017.04.020","article-title":"A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults","volume":"177","author":"KM Gray","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2006.04.014","article-title":"Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms","volume":"86","author":"AJ Budney","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-007-1020-8","article-title":"Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse","volume":"197","author":"M Haney","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.npp.1300310","article-title":"Marijuana withdrawal in humans: effects of oral THC or divalproex","volume":"29","author":"M Haney","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0376-8716(02)00084-4","article-title":"Effects of oral THC maintenance on smoked marijuana self-administration","volume":"67","author":"CL Hart","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2010.12.010","article-title":"Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial","volume":"116","author":"FR Levin","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugalcdep.2012.08.001","article-title":"The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users","volume":"128","author":"R Vandrey","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/npp.2013.54","article-title":"Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse","volume":"38","author":"M Haney","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1007\/s00213-016-4298-6","article-title":"Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users","volume":"233","author":"ES Herrmann","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"ref28","first-page":"33","article-title":"Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence","volume":"9","author":"M Prud'homme","year":"2015","journal-title":"Subst Abuse"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/cpt.109","article-title":"Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal","volume":"97","author":"DJ Allsop","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.drugalcdep.2016.02.020","article-title":"Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings","volume":"161","author":"JM Trigo","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamapsychiatry.2013.3947","article-title":"Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial","volume":"71","author":"DJ Allsop","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"ref32","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I\/P); Research NYB, editor: New York State Psychiatric Institute."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"JE Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"ref34","first-page":"343","article-title":"SAFTEE: a technique for the systematic assessment of side effects in clinical trials","volume":"22","author":"J Levine","year":"1986","journal-title":"Psychopharmacol Bull"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"M Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"M Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1360-0443.1988.tb00485.x","article-title":"Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations","volume":"83","author":"LC Sobell","year":"1988","journal-title":"Br J Addict"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire","volume":"86","author":"TF Heatherton","year":"1991","journal-title":"Br J Addict"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients","volume":"168","author":"AT McLellan","year":"1980","journal-title":"The Addiction Severity Index. J Nerv Ment Dis"},{"key":"ref40","article-title":"Beck Depression Inventory","author":"AT Beck","year":"1987"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00213-012-2954-z","article-title":"The drug effects questionnaire: psychometric support across three drug types","volume":"227","author":"ME Morean","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"ref42","article-title":"Manual for the profile of mood states","author":"DM McNair","year":"1971"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1046\/j.1360-0443.1999.94913114.x","article-title":"Marijuana withdrawal among adults seeking treatment for marijuana dependence","volume":"94","author":"AJ Budney","year":"1999","journal-title":"Addiction"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2008.12.010","article-title":"Reliability and validity of a short form of the Marijuana Craving Questionnaire","volume":"102","author":"SJ Heishman","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/sleep\/4.1.93","article-title":"The St. Mary's Hospital sleep questionnaire: a study of reliability","volume":"4","author":"BW Ellis","year":"1981","journal-title":"Sleep"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/npp.2012.14","article-title":"A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults","volume":"37","author":"BJ Mason","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/10550490701525665","article-title":"Treatment of cannabis use disorders: a review of the literature","volume":"16","author":"BR Nordstrom","year":"2007","journal-title":"Am J Addict"},{"key":"ref48","unstructured":"SAMHSA (2005) Brief COUNSELING for MARIJUANA DEPENDENCE A Manual for Treating Adults."},{"key":"ref49","doi-asserted-by":"crossref","DOI":"10.1037\/e436312005-001","article-title":"Brief counseling for marijuana dependence: a manual for treating adults","author":"KL Steinberg","year":"2005"},{"key":"ref50","article-title":"Cognitive therapy scale\u2014revised (CTS-R)","author":"IM Blackburn","year":"2001"},{"key":"ref51","article-title":"Motivational interviewing assessment: Supervisory tools for enhancing proficiency","author":"S Martino","year":"2006"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.chroma.2007.06.069","article-title":"Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry","volume":"1163","author":"RH Lowe","year":"2007","journal-title":"J Chromatogr A"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00216-011-5197-7","article-title":"Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry","volume":"401","author":"DM Schwope","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/ADM.0000000000000229","article-title":"Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence","volume":"10","author":"JM Trigo","year":"2016","journal-title":"A Case Series. J Addict Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/clpt.2010.318","article-title":"Subjective and physiological effects after controlled Sativex and oral THC administration","volume":"89","author":"EL Karschner","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"ref56","article-title":"Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers","author":"S Babalonis","year":"2016","journal-title":"Drug Alcohol Depend In press"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"S Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/npp.2015.367","article-title":"Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis","volume":"41","author":"M Haney","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.addbeh.2013.03.011","article-title":"Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings","volume":"38","author":"CJ Morgan","year":"2013","journal-title":"Addict Behav"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jcpt.12018","article-title":"Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report","volume":"38","author":"JA Crippa","year":"2013","journal-title":"J Clin Pharm Ther"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10550490500418997","article-title":"Cannabis withdrawal among non-treatment-seeking adult cannabis users","volume":"15","author":"ML Copersino","year":"2006","journal-title":"Am J Addict"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugalcdep.2010.04.010","article-title":"Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers","volume":"111","author":"KH Levin","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"ref63","first-page":"CD008940","article-title":"Pharmacotherapies for cannabis dependence","author":"K Marshall","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.dcn.2015.04.001","article-title":"Motivational and control mechanisms underlying adolescent cannabis use disorders: A prospective study","volume":"16","author":"J Cousijn","year":"2015","journal-title":"Dev Cogn Neurosci"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40429-014-0011-1","article-title":"Novel Pharmacologic Approaches to Treating Cannabis Use Disorder","volume":"1","author":"RE Balter","year":"2014","journal-title":"Curr Addict Rep"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"e44864","DOI":"10.1371\/journal.pone.0044864","article-title":"Quantifying the clinical significance of cannabis withdrawal","volume":"7","author":"DJ Allsop","year":"2012","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0190768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:00:52Z","timestamp":1589007652000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0190768"}},"subtitle":[],"editor":[{"given":"Ziva D.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,31]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0190768","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,31]]}}}